Step 4: dissolve gently Do not shake the vial
But Jay Campbell, founder of BioLongevity Labs, a manufacturer of research-grade peptides, remains skeptical that the outcome is a real positive for peptide access
Data & Methodology Results come from a May 2026 online survey of 2,491 U.S
This rapid effect on vessel structure occurs before gene expression changes fully manifest, suggesting direct molecular interactions alongside the longer-term transcriptional effects
Though the cause of ME/CFS is unknown, research indicates that 60-70% of cases are associated with viral infections (e.g., Epstein-Barr virus, H1N1, human herpesvirus, etc.).27 But the persistent symptoms experienced by long COVID patients are so similar to those seen in ME/CFS that some experts have proposed that long COVID may actually be another post-viral example of ME/CFS instead of a separate condition.28 While there appear to be a few different subtypes of ME/CFS,29 30 it stands to reason that patients with cases caused by COVID, or those most like long COVID, may see a similar restoration of an appropriate response from TA-1 peptide therapy as noted in the aforementioned ex vivo study.26 However, as with long COVID, far more research is needed to evaluate TA-1 as a potential treatment for ME/CFS